Reduction of chickens use to perform in vitro pre-screening of novel anticoccidials by miniaturisation and increased throughput of the current Eimeria tenella compound-screening model

In vitro models have supported important advances in biomedical sciences
and have significantly contributed to reduce the use of experimental
animals in different disciplines. We have developed an in vitro model for
the evaluation of potential anticoccidial properties of novel compounds
aimed to control chicken coccidiosis, a costly disease for the poultry
industry. This disease is caused by protozoan parasites of the genus
Eimeria (Apicomplexa), and it is mainly controlled by chemoprophylaxis
with ionophors and chemical anticoccidials; however, there is an overall
agreement about the limitation of these classical drugs and the need to
improve current methods of control. Anticoccidial activities of novel
compounds is currently evaluated by expensive experiments that involve
large numbers of chickens. The use of our in vitro model for the
pre-screening of essential oils led to a reduction of 67% of the chickens
used in the vivo trials for validation. In this study, we describe how
further optimisation of this in vitro model by miniaturisation can have an
additional impact on the number of chickens used for the generation of
parasite stocks for provision of the in vitro model (which cannot be done
in vitro). We have estimated that the use of one chicken could support the
evaluation of ten compounds with a 96-well plate format vs. only two with
a 24-well plate format, which means an 80% of chicken use reduction. In
this study, we have proved that the miniaturisation into a 96-well plate
format has perfectly mimicked the invasion and replication observed before
in the 24-well plate format. In addition, this format has allowed the
simultaneous pre-screening of higher numbers of anticoccidial drugs at
different concentrations following streamlined protocols in a more
cost-effective way, factors that are beneficial for a wider uptake of the
model by other researchers investigating anticoccidial compounds.